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Summary
Allelic variation in 9.7 kb of genomic DNA sequence
from the human lipoprotein lipase gene (LPL) was
scored in 71 healthy individuals (142 chromosomes)
from three populations: African Americans (24) from
Jackson, MS; Finns (24) from North Karelia, Finland;
and non-HispanicWhites (23) fromRochester,MN.The
sequences had a total of 88 variable sites, with a nucle-
otide diversity (site-specific heterozygosity) of .002
across this 9.7-kb region. The frequency spectrum.001
of nucleotide variation exhibited a slight excess of het-
erozygosity, but, in general, the data fit expectations of
the infinite-sites model of mutation and genetic drift.
Allele-specific PCR helped resolve linkage phases, and a
total of 88 distinct haplotypes were identified. For 1,410
(64%) of the 2,211 site pairs, all four possible gametes
were present in these haplotypes, reflecting a rich history
of past recombination. Despite the strong evidence for
recombination, extensive linkage disequilibriumwas ob-
served. The number of haplotypes generally is much
greater than the number expected under the infinite-sites
model, but there was sufficient multisite linkage dise-
quilibrium to reveal two major clades, which appear to
be very old. Variation in this region of LPL may depart
from the variation expected under a simple, neutral
model, owing to complex historical patterns of popu-
lation founding, drift, selection, and recombination.
These data suggest that the design and interpretation of
disease-association studies may not be as straightfor-
ward as often is assumed.
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Introduction
At the heart of the problem of the genetics of common,
chronic diseases is a need to understand the quantity,
nature, and arrangement of underlying DNA-sequence
variation and to formulate and test models for the map-
ping of that variation into interindividual variation in
risk of disease. History influences the way that we ap-
proach such difficult challenges, and, beginning with
Garrod’s (1902) classic work on alkaptonuria, the com-
mon approach essentially has been based on the view
that for each gene there are only two alleles, normal and
defective, segregating in the population. The theoretical
basis for this view was the assumption that most mu-
tations were deleterious and were eliminated quickly
from the population and that mutations occurred re-
currently between “wild-type” and harmful alleles. It of
course is commonly appreciated that multiple alleles oc-
cur, but the ramifications of allelic complexity often seem
to be underappreciated in contemporary biomedical ge-
netic studies.
A starting point for studies explaining the role of ge-
netic variation in the variation in risk of disease is a
description of the quality, quantity, and organization of
genetic variation within and between human popula-
tions. We are now in an era of the study of candidate
genes that may influence traits that are measures of the
biochemical or physiological features of disease. Most
studies of candidate genes rely, at least in part, on as-
certainment via clinical cases. This sampling approach
introduces a bias toward identification of alleles that are
associated with larger phenotypic effects. This is a sen-
sible starting point and has proved to be remarkably
effective in the identification of genes with particular
alleles that explain Mendelian disorders, such as cystic
fibrosis. Extensive family studies have demonstrated
that, for each simply inherited, Mendelian disorder, hun-
dreds of allelic variants in a particular gene may be as-
sociated with the disease phenotype. Less is known
about the variation in the same genes in the unaffected
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(or not yet affected) subset of the population, and clinical
ascertainment precludes an unbiased assessment of the
frequency, penetrance, and expressivity of each allele in
the population at large.
For the common chronic diseases having a complex
multifactorial etiology that aggregate but do not seg-
regate in accordance with Mendelian expectations, the
problem is to explain the reason for the aggregation.
Gene-mapping and physiological approaches have iden-
tified a number of candidate genes or chromosomal
regions where candidate susceptibility genes may be
found some day. When the physiology is understood, the
population can be screened for background levels of var-
iation in candidate genes, to find associations between
the genetic variation and the quantitative variation in
biochemical, physiological, and anatomic risk factors for
disease. However, analysis based solely on clinical cases
(the extremes of the phenotype distribution) may tell us
little about the effects of genetic variation in the rest of
the population.
Clearly, the most exhaustive way to assess DNA-se-
quence variation in the general population is to obtain
full sequence and haplotype information from large
numbers of individuals drawn randomly from different
populations. Haplotypes specify the phase relationship
of all heterozygous sites in a gene in a given individual
and should be important to the understanding of the
impact of genetic differences on variation in measures
of health, because a functional polypeptide is the product
of the haplotype (i.e., is coded by a single chromosome).
In this and a second article (Nickerson et al. 1998),
we present analyses of a systematic survey of variation
in a 9.7-kb region of the gene encoding the lipoprotein
lipase (LPL) molecule in 71 individuals from three pop-
ulations: (1) an African American population from Jack-
son, MS; (2) a population from the North Karelia region
of Finland; and (3) a mixed European-derived cohort
from Rochester, MN. The populations were chosen be-
cause they differ greatly in risk of coronary heart disease
(CHD) and because extensive epidemiological studies of
cardiovascular diseases are under way for all three pop-
ulations. The purpose of our studies is to determine the
role that variation in candidate genes, such asLPL, plays
in causing variation in risk of CHD in the general pop-
ulation, rather than in the clinical population. Our goal
in this article, however, is to understand the extent of
the variation in this CHD-susceptibility gene at the pop-
ulation level; how that variation is structured into hap-
lotypes and genotypes; and how they are distributed
among individuals within and between populations.
Sequence variation in LPL is expected to be associated
with some appropriate measure of physiological varia-
tion, such as the mean or variance of LPL protein levels
or LPL kinetics among individuals. In general, regions
coding for known functional sites in the LPL protein
seem to be conserved with the other lipases (Murthy et
al. 1996). The samples included in this study are too
small to provide much exonic variation, and not all the
LPL exons were included in the sequenced region. How-
ever, ∼75 exonic mutations have been identified already
(Santamarina-Fojo 1992; Stocks et al. 1992; Brunzell
1995; Yang et al. 1995; Murthy et al. 1996), and, at
least in some instances, the exon mutations have clinical
effects (Peacock et al. 1992; Reymer et al. 1995). As
determined from similar data and as shown by Nick-
erson et al. (1998), variation in LPL differs among hu-
man populations (Chamberlain et at. 1989; Hata et al.
1990; Thorn et al. 1990; Gotoda et al. 1991; Normand
et al. 1992; Hegele et al. 1994). For example, mutations
have been described that appear to be specific to par-
ticular populations of African Americans (Heizmann et
al. 1991) and French Canadians (Ma et al. 1991;Murthy
et al. 1996).
In our other article (Nickerson et al. 1998), we de-
scribe the allelic variation in the LPL gene segment se-
quenced in these individuals. Here, we describe the hap-
lotype structure of that variation and aspects of the
evolutionary (population-historical) processes that pro-
duced that variation. For this purpose, we also se-
quenced chimpanzee LPL, so that it could serve as an
outgroup for evolutionary and population genetic tests.
We compare our results with those expected under the
infinite-sites model, in which the evolution of DNA se-
quences is not affected by natural selection and each new
mutation occurs at a previously unmutated nucleotide
(Kimura 1969). To the extent that aspects of the ob-
served sample fit the expectations of the infinite-sites
model, other aspects of the data might be extrapolated
to the general population, with some confidence. Given
that there is already compelling evidence that human
populations deviate substantially from the assumptions
of the infinite-sites model (e.g., owing to major popu-
lation expansions in our history) (Harpending et al.
1998; Jorde et al. 1998), our data raise caveats regarding
generalities made about human genetic variation, espe-
cially with regard to understanding the distribution of
risk of disease within and among populations.
Subjects and Methods
Population Samples
The populations sampled included (1) a Jackson, MS,
population sample ( ) that is part of an ongoingn  24
National Heart Lung and Blood Institute study of hy-
pertension in African Americans; (2) the Finnish risk-
study population from North Karelia ( ), an arean  24
in eastern Finland that has had the world’s highest
known CHD risk and that has been studied for many
years (Tunstall-Pedoe et al. 1994); and (3) the population
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from the Rochester Family Heart Study ( ), a lon-n  23
gitudinal study of cardiovascular disease risk in the
Rochester, MN, area. All three samples were cross-sec-
tional with regard to their health status, and blood sam-
ples had been collected previously for epidemiological
studies.
DNA Sequencing
DNA sequencing was performed on diploid geno-
types, in accordance with procedures described in detail
elsewhere (Nickerson et al. 1998). In brief, PCR-ampli-
fication products were used as templates in separate cy-
cle-sequencing reactions to prepare fluorescent-tagged
products for analysis on an ABI 373 automated se-
quencer. Each diploid sequencing trace was analyzed by
use of procedures and software that can resolve heter-
ozygotes, under replicable quality-control conditions, as
described by Nickerson et al. (1997). Extensive confirm-
atory resequencing also was performed on these samples
(Nickerson et al. 1998).
Chimpanzee LPL Sequencing
Sequence from the LPL gene also had been obtained
from chimpanzee (Pan troglodytes). PCRwas performed
with the same array of primer pairs, and dye termination
cycle sequencing was performed on the products. Not
all genomic PCR reactions were successful, and not all
insertion/deletion variations were resolvable; however,
of the 9,734 sites scored in humans, the chimpanzee
homologue was aligned and scored for 8,091 of these
sites, including reference sites 1–1636, 1898–2916,
2938–3307, 3734–4124, 4289–4675, 5222–5849,
6029–6571, and 6618–9734. The GenBank accession
numbers for LPL reference sequences are AF050163 for
human and AF071087–AF071094 for chimpanzee.
Haplotype Determination
The samples were sequenced on diploid DNA, which
yields unphased genotype data, and then the haplotype
phases were determined. Traditionally, pedigree analysis
has been used to infer linkage phase. Haplotypes also
can be determined directly, for each pair of sites, by
allele-specific PCR (AS-PCR). An important question is
whether it is necessary to test in this manner every pair
of sites in multiple-site heterozygotes or whether the data
have enough structure to allow some haplotypes to be
inferred. In this study, we employed an iterative ap-
proach that determines some phases by AS-PCR, then
calls phases by an inferential procedure, and then tests
the calls by further AS-PCR until no calls are violated
by the empirical tests.
Complete homozygosity across a region or heterozy-
gosity at a single site allows unambiguous assignment
of a haplotype for that region. Our algorithm identifies
a set of putative haplotypes in a sample by “subtracting”
such unambiguous haplotypes in individuals having
more than one heterozygous site (Clark 1990). The ra-
tionale for this approach is that, for any haplotype that
is common enough that homozygotes can be found in
the sample, the sample is expected to have several het-
erozygotes bearing one copy of that haplotype. The two
types of potential errors are failure to resolve all hap-
lotypes, which occurs if there is an individual hetero-
zygous for two unique haplotypes in the sample, and
misclassification. Both errors are corrected empirically
by determination of the linkage phase by AS-PCR.When
used alone, the accuracy of the inferential procedure de-
pends on several population genetic parameters, includ-
ing the population size, the sample size, the mutation
rate, and the rate of intragenic recombination, but this
inferential procedure can be surprisingly effective at in-
ferring the haplotype structure hidden in a set of un-
phased genotype data (Clark 1990). In conjunction with
AS-PCR, the method can be iterated until accuracy is
assured. Maximum-likelihood methods for haplotype
inference (Excoffier and Slatkin 1995; Hawley and Kidd
1995) do not work with data of this type, because they
build the likelihood based on the fit to Hardy-Weinberg
proportions. Such a likelihood has no information in the
context of data such as those for our LPL sequences,
because every sampled individual is a heterozygote.
The LPL sequences required numerous AS-PCR tests
for resolution and verification of the haplotypes. For
several different subsets of AS-PCR phase calls, the in-
formation from those phase calls was used to seed the
inferential algorithm. Each run gave inferred haplotypes
for different but overlapping sets of sites. Confidence in
the inferred haplotypes came from two observations.
First, a sufficient number of molecular calls had been
made such that the multiple runs of the algorithm (using
different subsets of sites) gave identical calls. Second, we
were able to verify the calls by performing runs seeding
the algorithm with a subset of AS-PCR calls and by
comparing the resulting inferred haplotypes versus those
that already had been tested molecularly. For example,
the AS-PCR calls for five sites were omitted from the
input, and the algorithm was run. These five sites oc-
curred in 22 five-site heterozygotes, 1 four-site hetero-
zygote, 2 three-site heterozygotes, and 3 two-site het-
erozygotes, for a total of 235 site pairs for which the
linkage phase needed to be called. The algorithm pro-
duced calls for these site pairs, and subsequent checking
with the molecular calls showed that all 235 site pairs
were correct. Finally, several inferred haplotypes were
verified post hoc by targeted AS-PCR for particular pairs
of sites.
This method of haplotype inference has two weak-
nesses. First, a lot of effort is required for the AS-PCR:
for the LPL sample, 1560 AS-PCR reactions were per-
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formed. Second, the only way to call the phase for sin-
gleton and doubleton sites is to perform direct molecular
tests, such as AS-PCR. Because singleton and doubleton
sites are at such low frequency in the population, they
yield very little information about the gene’s history, and
we have not yet determined their linkage phase.
Data Validation
The procedure of calling heterozygous sites in the se-
quencing of chromatograms is not applied widely, and
the PolyPhred program plays a key role in optimizing
this procedure. As outlined by Nickerson et al. (1998),
several lines of evidence were used to assure accuracy
of the sequences, including scoring of both strands, rep-
lication of a large fraction of the runs, and scoring of
all heterozygous sites by AS-PCR for the haplotype calls.
In addition, the structure of the data is consistent with
only an exceptionally low error rate. We cite eight rea-
sons for this: (1) Most of the coding variants identified
in this study had been seen by others, as was expected
for such small samples. (2) The coding region had lower
nucleotide diversity than the noncoding regions, as was
expected. (3) For subsamples of the data, the number of
segregating sites increased with an increase in sample
size, in close approximation to the infinite-sites model.
(4) Overall, the nucleotide diversity was within the range
observed by others. (5) Individual sites that were ana-
lyzed singly revealed a good fit with Hardy-Weinberg
proportions of genotypes. Although the error rate would
have to be inordinately high to cause a rejection based
on any one site, the lack of a trend in departures from
Hardy-Weinberg proportions, across sites, suggests that
the aggregate test has reasonable power. (6) The chim-
panzee sequence—which was obtained at an indepen-
dent laboratory, by K.M.W. and A.B.—showed that
every polymorphic site in humans had one or the other
nucleotide present in chimpanzee. (7) If errors were fre-
quent, they most likely would occur as singleton calls
(false calls of heterozygotes). This would result in an
excess of singletons, and the observed count of singletons
was slightly below that expected under the infinite-sites
model. (8) False calls of heterozygotes also would be
expected to generate sites with three or four different
segregating nucleotides, which were not observed. Fi-
nally, in work that is in progress, K.M.W. and A.B. in-
dependently have sequenced a comparable sample of
Amerindians and have identified variations at 150 of the
same sites, with all other sites either being invariant for
one of the nucleotides observed in the original data set
or showing a new variant in addition to the observed
nucleotide.
Results
The Amount of Genotypic Variation
A detailed description of the amount, quality, and dis-
tribution of allelic variation in the LPL gene segment
sequenced in the sample of 71 individuals from three
populations appears in the article by Nickerson et al.
(1998). In brief, 88 variable sites in the 9,734 bp of LPL
were observed. With the exception of a polymorphic
tetranucleotide repeat, all segregating positions, includ-
ing the nine insertion/deletion differences, had only two
alternative nucleotides. Ten sites in our sample of 142
chromosomes had only a single copy of the rarer nu-
cleotide (singletons), and another 10 sites had only two
copies of the rarer nucleotide (doubletons). Overall, the
nucleotide diversity (i.e., the average heterozygosity, in-
cluding unvarying sites) for the 9,734-bp region was
, which is within the range of previous es-.002 .001
timates but is somewhat higher than average estimates
(Li and Sadler 1991). Of the variable sites, 9 were in-
sertions or deletions, and 79 were single-nucleotide sub-
stitutions. Only 7 of the single-nucleotide polymor-
phisms (SNPs) were in exons (sites 145, 2849, 6176,
6196, 6203, 7754, and 9040). Three mutations changed
an amino acid (2849, AsnrSer [Gagne and Gaudet
1995]; 6176, ValrMet; and 6203, ThrrAla), and one
mutation (9040) introduced a premature termination co-
don in the mRNA (Hata et al. 1990). The coding var-
iants at positions 9040 and 2849 had been reported
previously (by Reina et al. [1992] and Wiebusch et al.
[1996], respectively), whereas those at 6176, 6203, and
7754 had not. We did not observe any individuals who
are completely homozygous for this 9.7-kb region, and
only two individuals varied at only a single site, whereas
two individuals varied at 38 sites. The average individual
is heterozygous at 17 sites.
Two estimates of nucleotide variation commonly are
used (Hartl and Clark 1997). A central parameter in
population genetic models for the balance between mu-
tation and random genetic drift is , where Nev  4N me
is the effective population size and m is the mutation rate
per nucleotide site. This parameter summarizes the rate
at which processes of mutation and random genetic drift
generate and maintain variation within a gene, under
conditions in which natural selection has not been op-
erating. The degree to which characteristics of the data
conform to the predictions of the infinite-sites model has
been used as a test of goodness of fit of the model. Such
a test begins with estimation of the relevant model pa-
rameters, the most important being v. From the number
of segregating sites, S, v has been estimated as ˆv 
, where n is the sample size (Watterson 1975).1n1S/ i1 i
Although the count of segregating sites does not capture
all the information in the sample, under the infinite-sites
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Table 1
Population Genetic Statistics for LPL Variation
Population
No. of
Sites v p
Tajima’s
D* C/v
Jackson 78 .0018  .0006 .0020  .0010 .812 1.443
North Karelia 56 .0013  .0004 .0016  .0008 1.007 .371
Rochester 59 .0014  .0004 .0020  .0010 1.775 .335
Total 88 .0016  .0004 .0020  .0010 .909 .693
model the frequency spectrum of sites is determined by
v, which in turn is determined by S. Note that violation
of the assumptions of the infinite-sites model will lead
to bias in the estimate of v. In particular, if multiple
mutations occur at individual nucleotide sites, use of
estimates derived from the finite-sites model would be
more appropriate (Tajima 1996).
A second measure of sequence variability is p, the
average heterozygosity per site, where heterozygosity is
the probability that a site will be heterozygous in an
individual sampled from a randomly mating population.
If the population sample fits the infinite-sites model, v
and p have equal expectation. Table 1 gives the estimates
of v and p for each of the three populations and for the
pooled sample. In each case, is greater, suggesting that,pˆ
for the given number of varying sites, there is an excess
of heterozygosity. Comparison of these two measures
was formalized, by Tajima (1989), in the test statistic
D, which is divided by the SD of this difference.ˆpˆ v
Despite the consistency of excess heterozygosity, we can-
not reject the null hypothesis of neutrality.
Under the infinite-sites model, the expected number
of singletons is simply v (Fu and Li 1993). On the basis
of the observed number of segregating sites, our estimate
of v for the entire 9.7-kb region is 15.94 (the estimates
in table 1 were calculated on a per-site basis). We ob-
served 10 singletons instead of 16 and applied the ap-
propriate test for the significance of this departure (Fu
and Li 1993). The test statistic for this aspect of the data
is D*, for which the expectation is 0 and the SD is 1.0.
For our data, , which is not significant∗D  0.757
( ). Under this model, the expected number of het-P 1 .05
erozygous sites per individual is also equal to v 
, which is close to the observed count of 17. To15.94
the extent that there is similarity between observed and
expected values for these characteristics, one could infer
that the populations are evolving in accordance with the
infinite-sites model.
The upper panel of figure 1 provides the distribution
of relative nucleotide frequency, in order of descending
rank of the 87 variable sites (the tetranucleotide repeat
violates the assumptions of the infinite-sites model and
was not considered). Also shown are the expected fre-
quencies of alleles at the 87 sites, under the infinite-sites
model. These were generated by sampling from the dis-
tribution given by P(j copies in a sample of n genes) 
1/ja, where (eq. 9.69 in Ewens 1979). Con-1n1a   i1 i
sistent with the Tajima (1989) and Fu and Li (1993)
tests, the site-frequency distribution is in good accor-
dance with the infinite-sites model, although there is
some excess heterozygosity at sites of intermediate rank.
The good fit to the infinite-sites model is consistent with
the very small effect of a correction under the finite-sites
model. Even if we allow for extensive variation, among
sites, in the mutation rate (following a gamma distri-
bution with parameter ), the estimate of v, on aa  .1
per-site basis, is changed from 0.002 (infinite-sites
model) to 0.00206 (finite-sites model) (eq. 24 in Tajima
1996).
Population Subdivision
Variation in the gene was distributed unevenly among
the three populations. Fifty-one sites varied in all three
populations. However, 5 sites were found to vary in only
the Rochester population, 2 sites in only the North Ka-
relia population, 3 sites in only the two European-de-
rived populations, and 27 sites in only the Jackson pop-
ulation. One way to quantify the degree of population
diversity is with the statistic FST (Wright 1931), which
essentially is the genetic variance (heterozygosity) among
populations, divided by the genetic variance of the total
population. The nucleotide-site data yielded an estimate
of , with a 95% confidence interval ofF  .065 .014ST
(.041–.0922), obtained by bootstrapping over sites (Weir
1996). The data allow strong rejection of the null hy-
pothesis of homogeneity, by permutation tests (Hudson
et al. 1992). The level of population subdivision is typ-
ical of findings in studies of other genes (Cavalli-Sforza
et al. 1994).
The FST analysis is based on individual nucleotide-site
data. As the size of the examined region increases, more
and more haplotypes become unique to each population,
and eventually every haplotype will be unique to each
individual. This kind of scaling problem is important to
keep in mind when haplotypic variation over regions as
large as or larger than that examined here is considered.
As described in Subjects and Methods, we obtained link-
age-phase information from AS-PCR tests and by infer-
ence, to obtain 88 distinct haplotypes in the sample.
Figure 1 Top, Observed relative frequencies of the rarer nucleotide at each varying site (indicated by dots). In general, these frequencies
are close to the frequencies expected under the infinite-sites model (indicated by the solid line), for the given sample size and observed number
of segregating sites. Error bars are1 standard error and were obtained by repeated sampling from the expected distribution given in the text.
Bottom, Distribution of observed haplotypes when subsets of the data were resampled. The number of distinct haplotypes (indicated by the
solid line, with error bars of 1 standard error) are far in excess of the number expected under the infinite-alleles model (lower solid line),
for the given sample size and the estimate .v  4N m  15.94e
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Only 3 of the 88 haplotypes were present in all three
populations, whereas 1 haplotype was present in the
Jackson and North Karelia populations and 3 were pres-
ent in the North Karelia and Rochester populations.
Fully 21 haplotypes were unique to the North Karelia
population, 25 haplotypes were unique to the Rochester
population, and 35 haplotypes were unique to the Jack-
son population. When the data are treated as a single
locus with 88 alleles, FST for the LPL haplotype data is
. This is lower than the nucleotide-site.0197 .0133
estimate of FST, because the probability of haplotype
identity remains very lowwhether alleles within the same
population are examined or alleles from two different
populations are compared.
Haplotype Variation and Intragenic Recombination
Whereas the infinite-sites model yields an expected
number of segregating sites for a given sample size, pop-
ulation size, and mutation rate, the infinite-alleles model
provides an expected number of distinct alleles (in this
case, haplotypes) for these same parameters. Both mod-
els serve as a null model in which the only forces acting
on the sequence variation are mutation and random ge-
netic drift. The difference lies in the manner in which
mutations are thought to occur. In the infinite-alleles
model, each mutation is assumed to generate a distinct
allele, and no recombination is assumed to occur. In
applying this model, we assumed initially that the pop-
ulation is not subdivided and is at equilibrium. The
lower panel of figure 1 shows the correspondence be-
tween the infinite-alleles model and the mean and var-
iance of the numbers of distinct haplotypes observed
when we repeatedly drew samples of various sizes from
the observed data. The data showmanymore haplotypes
than the model predicts for the value of v estimated from
the number of segregating sites. One possible cause for
the excess is intragenic recombination. Gene conversion
is formally distinct from intragenic recombination, but,
for purposes of discussion, we refer to the consequences
of both processes. We can begin to assess the likelihood
that intragenic recombination has played a role in the
generation of haplotype diversity by directly examining
the variation. Figure 2 shows the 88 haplotypes by plot-
ting a dash (–) for the more common variant and a circle
() for the rarer variant at each variable site. The hap-
lotypes are arranged in the order in which they appear
in a tree of sequence similarities (by use of the neighbor-
joining method; Saitou and Nei 1987), which clusters
together the haplotypes that are most similar. One fea-
ture of the haplotypes is clear: there is a cluster of sites,
in the 3′ half of the sequenced region of LPL, that par-
titions the haplotypes into two major clades. Some hap-
lotypes, however, appear to have patterns that have been
interchanged in the 5′ and 3′ ends. Such patterns reflect
a history of intragenic recombination, whichwe consider
below.
With 88 segregating sites, there is an astronomical
number of potential haplotypes, but only a small frac-
tion of these haplotypes would be observed in any finite
population. In the absence of intragenic recombination,
repeated mutation, or back mutation, the maximum
number of haplotypes that one expects to see for s sites
is haplotypes. A simple graph indicating intragenics 1
recombination is a sweeping window plot showing an
arbitrary window size of five sites at a time and counting
the number of distinct haplotypes for each set of five
sites (fig. 3). Many sets of five adjacent sites in the LPL
gene exhibit more than six haplotypes, which is indic-
ative of intragenic recombination. When 10 sites are
considered at one time, the same regions show 111 hap-
lotypes. Both window sizes show a marked decrease in
the number of distinct haplotypes in a region in the 3′
half of the gene, suggesting less intragenic recombination
in this region.
Several statistical tests for intragenic recombination
have been devised. The tests of Sawyer (1989) and Ste-
phens (1985) appear to be best suited to identification
of rare recombination or conversion events (also see Be-
tra´n et al. 1997; Jakobsen et al. 1997). Both tests clearly
show that there is a large amount of variation, but they
yield little useful quantitative information, because there
appears to be so much recombination. The test of Hud-
son and Kaplan (1985) is based on the four-gamete test,
which is a two-site analogue to figure 3. A population
that has only one haplotype—for example, A-B—may
mutate to give A-b and a-B. Haplotype a-b can arise
only through recombination or repeated mutation. We
will assume that repeated mutation is a less likely ex-
planation and that all site pairs having four gametes
must have had a recombination occur between them at
some time in their ancestral history. Repeated mutation
will be considered further in another article, but the in-
itial assumption that repeated mutation is rare stems
from the good fit with the infinite-sites model and the
lack of even a single observed site with more than two
segregating nucleotides. When these caveats are consid-
ered, simply tallying the fraction of site pairs that have
all four gametes present will provide an indication of
intragenic recombination. Note that a single recombi-
nation event can result in multiple site pairs having all
four gametes in the sample; thus, the inference of num-
bers and locations of recombination events requires con-
sideration of the locations of the site pairs that have four
gametes present.
Figure 4 shows the site pairs for which four gametes
were present in the sample of 142 chromosomes. The
distribution of such pairs shows that intragenic recom-
bination is likely to have occurred throughout the LPL
gene. Hudson and Kaplan (1985) devised an estimate
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Figure 2 Illustration of the 88 haplotypes. For each site, a dash (–) represents the common nucleotide, and a circle () represents the
rarer nucleotide. The haplotypes are arranged in order of the tips of a neighbor-joining tree, so that more-similar haplotypes are clustered. Note
that the haplotypes fall into two major groups, divided roughly in the middle of the list, and that some intragenic recombination events can
be identified by sight. The penultimate line indicates the positions of the inferred minimum recombination events. The last line indicates the
chimpanzee haplotype.
for the minimum number of recombination events that
is consistent with the matrix of four-gamete results. For
our data, the estimate of the expected number of recom-
bination events is 45. Our estimate of the minimum
number is 20. Although this method yields a uniform
distribution of recombination events along the gene (fig.
2, bottom), the methods of Jakobsen et al. (1997) and
Crandall and Templeton (1998) identify a hot spot in
the middle of the sequenced region. In applying the four-
gamete tests to the Jackson, North Karelia, and Roch-
ester samples separately, we found evidence for a min-
imum of 17, 14, and 13 past recombination events,
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Figure 3 Observed number of distinct haplotypes, in slidingwin-
dows of 5 bp (dashed line) and 10 bp (solid line). For a window of
size s, the maximum number of haplotypes in a population, in the
absence of intragenic recombination, back mutation, or recurrent mu-
tation, is . Observation of regions with a number of haplotypess 1
greater than indicates numerous recombination events in thes 1
ancestral history of that segment of the gene.
Figure 4 Plot for the four-gamete test. A blackened square in-
dicates that the given site pair had all four possible gametic phases.
The presence of all four gametes in site pairs also suggests intragenic
recombination. The diagonal line, with exons 4–9 labeled, indicates
the location of each varying site along the gene.
respectively. Because the Jackson sample had more seg-
regating sites and likely is more admixed than the other
populations, there is greater power to discriminate re-
combination events in the Jackson sample; thus, these
data do not suggest variation among populations in lev-
els of recombination.
To determine whether the method by which haplo-
types were inferred might be responsible for this plethora
of four-gamete site pairs, we evaluated the unphased
(raw) genotype data. When the unphased data were con-
sidered by two sites at a time, the double homozygotes
and single heterozygotes each provided unambiguous in-
formation about haplotypes. If we did not have linkage-
phase information, double heterozygotes did not allow
direct counts of haplotypes; therefore, they were not
used in this analysis. Thus, the unphased data provide
a minimal bound on the true number of site pairs with
all four gametes. Of the 2,211 site pairs that could be
tallied, 1,187 had all four gametes present. When we
employ the complete phase-known data, some of the site
pairs that had only three unambiguous haplotypes now
will have all four haplotypes present. The phase-known
data added only 223 four-gamete site pairs (for a total
of 1,410). This result also indicates that, in general, the
recombination events that produced these gametes oc-
curred far enough in the past for the gametes to become
frequent enough to be present in unambiguous genotype
combinations even in a small sample.
Intragenic recombination results in a reduction in the
variance of the pairwise mismatch distribution. Hudson
(1987) made use of this fact to devise an estimate of the
ratio of , where is a compound measureC/v C  4N ce
of effective population size multiplied by the recombi-
nation rate between flanking sites, c, and where v 
, as before. For the LPL data, application of Hud-4N me
son’s estimate gives for the entire sample,ˆ ˆC/v  0.693
and, for the Jackson, North Karelia, and Rochester sam-
ples, the estimates were 1.443, 0.371, and 0.335, re-
spectively (table 1). These numbers suggest that the rate
of intragenic recombination between a pair of sites is
within a factor of two of the mutation rate (again with
the caveat that repeated mutations are assumed not to
have been important in producing this variation). It
again appears that the Jackson population has a higher
recombination rate than the other populations, probably
owing to admixture, but the statistical significance of
this difference was not determined. Recent refinement
of this estimation procedure gave essentially the same
results (Hey and Wakeley 1997; Wakeley 1997). High
levels of intragenic recombination in human genes had
been inferred in previous studies (Chakravarti et al.
1984, 1986).
Linkage Disequilibrium
Despite the apparently high rate of intragenic recom-
bination, considerable linkage disequilibrium still exists
among pairs of sites from these LPL data. Figure 5
shows results of pairwise tests, indicating those site pairs
that exhibited significant disequilibrium by a Fisher’s
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Figure 5 Plot showing pairwise linkage disequilibrium, indicated
by a blackened square, for site pairs with a significant Fisher’s exact
test ( ) and no correction for multiple comparisons. In com-P ! .001
parisons of site pairs in which both sites have rare nucleotides, there
can be complete disequilibrium (one of the four possible gametes hav-
ing a count of 0), yet the Fisher’s exact test can be not significant. Site
pairs that lack the power to test a significant association are indicated
by a dot in the center of the square. The layout of the figure is the
same as that for figure 4.
exact test (Weir 1996). Figure 5 shows a tendency for
more cases of significant disequilibrium in the 3′ half of
the gene, corresponding to the somewhat lower apparent
recombination rate in this region, indicated by figure 3.
For each pair of sites, we calculated the linkage-dise-
quilibrium statistic D, defined as , where isP  p p Pij i j ij
the frequency of the haplotype with nucleotides i and j
at the two sites and where and are the frequenciesp pi j
of nucleotides i and j, respectively. A test of overall link-
age disequilibrium, based on the numbers of observed
and expected signs of D (Lewontin 1995), revealed a
significant excess of cases of disequilibria in which rare
alleles were associated.
The linkage disequilibria calculated for all pairs of
sites were correlated significantly between the samples
(Jackson vs. North Karelia, ; Jackson vs. Roch-r  .792
ester, ; and North Karelia vs. Rochester,r  .592 r 
; for all correlations), and there were no.673 P ! .0001
cases of significant disequilibrium in opposite directions,
from one sample to another. This suggests that the basic
pattern of disequilibrium that will be detected in samples
of this size reflects events that occurred long ago in the
ancestral population common to all of the current sam-
ples. The replicability of this pattern may be a useful
tool for mapping strategies. Of the 2,211 site pairs for
which linkage disequilibrium could be assessed, 795
were in complete disequilibrium (having only three of
the four gametes present), and six site pairs were in ab-
solute disequilibrium (having only two of the four gam-
etes present). In addition, there was a highly significant
higher-order linkage disequilibrium, as assessed by
Brown et al.’s (1980) test. In this test, the observed var-
iance of the pairwise mismatch distribution is compared
with the variance for randomly permuted data (the null
hypothesis of linkage equilibrium). The observed vari-
ance (125.72) was greater than the variance of 1,000
permuted trials (for which the mean variance was
18.22); thus, the evidence for multisite disequilibrium is
strong.
Pairwise disequilibrium also was inferred from the un-
phased genotype data (again, in an effort to see if any
attribute of the pattern of disequilibrium might be an
artifact of the haplotype-inference procedure). Following
the method of Hill (1974), we assumed that genotypes
are formed by random union of gametes and obtained
maximum-likelihood estimates of gametic frequencies
and of D, the composite linkage-disequilibrium param-
eter from the genotype counts. The values of D and D
were highly correlated ( ; ).r  .983 P ! .0001
Similarity Relationships among LPL Haplotypes
Gene trees typically are drawn to portray the sequence
similarity of a sample of haplotypes. Without recom-
bination or recurrent mutation, a series of such se-
quences will form a cladistic, or hierarchical, relation-
ship that reflects the ancestral historical order of the
mutations that have occurred. Intragenic recombination,
as reflected in the LPL-gene data, makes it impossible
to do this, because, when gene segments are exchanged
among alleles, the sequences no longer have a branchlike
cladistic structure (the tree has loops as well as
branches). The full network of all 88 LPL haplotypes
is a complicated tangle of loops and is not shown.
One feature of the relationships among haplotypes
that is clear without drawing a tree is the tendency of
the haplotypes to cluster into two major clades. This
pattern is evident by inspection of the raw data presented
in figure 2. The distribution of pairwise mismatches be-
tween alleles has been examined in several genes, for the
purpose of drawing inferences about past demographic
history (Slatkin and Hudson 1991; Rogers and Har-
pending 1992). Figure 6 shows that the mismatch dis-
tribution for LPL is clearly bimodal, reflecting the two
deep clades apparent in figure 2. In the absence of in-
tragenic recombination, the expected mismatch distri-
bution under the infinite-sites model is geometric (Wat-
terson 1975), but the sampling properties of the model
are such that wide differences from this expectation are
not uncommon.
In order to test the significance of the departure of the
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Table 2
Frequencies of Haplotypes in Each of the Two Major LPL Clades
CLADE
FREQUENCY, BY POPULATION
Jackson North Karelia Rochester Total
1 29 34 30 93
2 19 14 16 49
Total 48 48 46 142
Figure 6 Pairwise mismatch distribution for LPL, constructed by counting the number of differences between all pairs of the 142
chromosomes in the entire sample. The pairwise mismatch distribution has a bimodal distribution, consistent with the twomajor clades identified
in figure 2.
observed mismatch distribution from the neutral expec-
tation, we performed a coalescence simulation. By ap-
plying the algorithm of Hudson (1990), for the gener-
ation of samples of genes with intragenic recombination,
we generated 1,000 simulated sets of 142 haplotypes
having the observed number of segregating sites and hav-
ing two clades, of sizes 93 and 49. For each such sample,
we scored the ratio of the sum of the squared number
of mismatches between clades over that within clades
(analogous to an F test for the analysis of variance). This
gave the null distribution for a score of how distinct the
two major clades were. The observed value of this test
statistic was 6.44, which fell into the bottom 0.7% of
the distribution. We conclude that the degree of sepa-
ration of the two major clades significantly exceeds the
separation expected by chance.
One obvious cause for such clade separation is geo-
graphic isolation. Table 2 shows the counts of haplo-
types in clades 1 and 2, for each of the three populations
studied. For table 2, the x2 test of heterogeneity yielded
, which is not significant. Thus, the two ma-2x  0.561
jor clades are represented equally in all three population
samples, and geographic isolation cannot explain the
depth of the split. We conclude that these two major
clades are very old and have been maintained in the
human population for a longer period than would be
expected if their variation had no physiological effect.
Additional tests for evolutionary forces that may impact
both this variation and the dating of when the twomajor
clades split require comparison with an outgroup se-
quence such as that of chimpanzee.
Comparison of Human Polymorphism versus
Divergence from Chimpanzee
Chimpanzee and human LPL differ at 112 sites, and,
for every site that is variable in humans, one of the
nucleotides is present in the chimpanzee sequence (see
the bottom line of fig. 2). One of the most powerful
means of detecting the role of natural selection in shap-
ing the distribution of genetic variation is a systematic
comparison of levels of polymorphism within a species
versus the divergence between species (Hudson et al.
1987). If two genes are undergoing neutral evolution,
so that the fate of new mutations is determined entirely
by random genetic drift, and if their levels of interspecific
divergence are similar (suggesting that the rates of mu-
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Table 3
Contrasts between Human Polymorphism and Human/Chimpanzee
Divergence in LPL
TYPE OF VARIATION
NO. OF SITES
PROB-
ABILITY
Poly-
morphic
Human/
Chimpanzee
Divergent
Insertion/deletion 9 6 .152
Single-nucleotide difference 79 106
Coding 9 6 .150
Noncoding 81 108
Replacement 4 0 .036
Silent 84 112
tation are the same), then their levels of intraspecific
polymorphism likewise are expected to be similar. This
is because, under the neutral model, polymorphism is
determined by the mutation rate and the effective pop-
ulation size. A formal test comparing intraspecific poly-
morphism to interspecific divergence can be performed
by estimation of v and divergence time by the least-
squares method (Hudson et al. 1987). The test of the
data’s goodness of fit to the model provides a test of
neutrality. For the LPL data, we first divided the se-
quenced portion of the gene into the 5′ and 3′ halves and
asked whether the two halves were consistent in their
levels of polymorphism and divergence. The estimates
of v for the two halves were not found to be heteroge-
neous, and the overall x2 test for homogeneity of poly-
morphism and divergence was , which is not2x  0.234
significant. We conclude that the effects of mutation,
drift, and possibly selection that are at work on the
variation in LPL are not measurably different in the 5′
and 3′ halves of the sequenced portion of the gene.
Next, we performed the test by Hudson et al. (1987),
comparing polymorphism and divergence levels in the
entire 9.7 kb of the LPL sequence versus those found
in b-globin (Harding et al. 1997) and testing the null
hypothesis that the same neutral parameters fit both loci.
b-Globin divergence between human and chimpanzee in
was quantified by alignment of chimpanzee sequence
(GenBank accession number X02345), which contains
5′ sequence and most of the coding region, with the
human sequence (GenBank accession number L26463).
In the 3 kb examined by Harding et al. (1997), 35 var-
iable nucleotides were found in a sample of 349 chro-
mosomes. In the 2,207 bp of the sequence aligned with
chimpanzee, there was an average of 26 differences. The
test yielded (1 df; ), reflecting no de-2x  0.40 P  .53
parture from uniformity across loci. Use of only the 17
varying sites in the region of low recombination in b-
globin also yielded no significant departure ( ,2x  0.06
1 df; ). This result tells us only that b-globin andP  .79
LPL have similar patterns of polymorphism and diver-
gence; so, variation in both genes could be neutral, or
it could be undergoing the same pattern of natural se-
lection. As more data to assess levels of polymorphism
and divergence at the nucleotide level become available,
this will be an informative test for comparison of ho-
mogeneity across different genes.
Another test that makes use of interspecific divergence
tallies two (or more) classes of substitutions within and
between species and tests their homogeneity (Templeton
1987). The chimpanzee sequence exhibited 112 fixed
differences from humans, over 8,091 sites examined. Six
of these differences were insertion/deletion differences
(including an absence of the AAAT tetranucleotide re-
peat, seen in humans), and 106 were single-nucleotide
differences. This contrasts with the 9 insertion/deletion
polymorphisms and 79 SNPs within humans. A simple
contingency table yields a Fisher’s–exact-test tail2# 2
probability of .152 (table 3). Furthermore, 4 of the hu-
man/chimpanzee differences were coding, and the re-
maining 108 were noncoding, compared with 7 coding
polymorphisms and 81 noncoding polymorphisms
within the human sample. This contrast also is not sig-
nificant. Finally, we can test the divergence and poly-
morphism levels of silent versus replacement differences,
a test used by McDonald and Kreitman (1991) on Adh
sequenced in Drosophila species, to show that interspe-
cific comparisons revealed a striking excess of amino
acid replacements. Within the human data, 4 sites were
replacement polymorphisms, and 84 were silent,
whereas the human/chimpanzee comparison found no
replacements and 112 silent differences. This test yielded
a significant result (for Fisher’s exact test, ),P  .036
indicating that, relative to the amount of amino acid
divergence between the two species, there is a slight ex-
cess of replacement polymorphism in humans. This pat-
tern is the opposite of the most common pattern of de-
parture found by use of the McDonald-Kreitman test.
Discussion
The four major conclusions that may be drawn from
the data presented here all have important consequences
for the design of studies in which the goal is to identify
genetic factors associated with the risk of common dis-
eases having a complex multifactorial etiology. First,
LPL exhibits a level of nucleotide variability that is
somewhat higher than the average reported values (Li
and Sadler 1991; Hey 1997). For a nucleotide diversity
of .002, we expect that, between a random pair of chro-
mosomes, two nucleotides will differ for every 1 kb that
is compared. Comparisons between pairs of alleles from
different individuals will identify additional varying
sites; thus, the number of varying sites in a sample clearly
will increase with an increase of sample size. The ob-
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servation of 88 variable sites in a sample of 142 chro-
mosomes fits the infinite-sites model well. The obser-
vation of such a complex pattern of variation across this
gene and among populations underscores the utility of
sequencing the gene of interest, in a representative sam-
ple of individuals, early in a study, to evaluate the in-
fluence of genetic polymorphism on variation in risk
factors and risk of disease. Obtaining an accurate, quan-
titative picture of the distribution of site variation and
the structure of linkage disequilibrium will be necessary
for optimization of the design of subsequent association
studies.
The second major conclusion drawn from these data
is that, at the nucleotide-sequence level, the human pop-
ulation does exhibit considerable population structure.
By this we mean that there are segregating nucleotide
variants with relative frequencies that differ widely from
one group to another. For example, not unexpectedly,
the Jackson population contains more variation; in part,
this is because Africans, in general, are genetically more
variable than people from other regions of the world
(Cavalli-Sforza et al. 1994) and also because African
Americans are admixed between Africans and Europe-
ans, which adds an additional source of variability. In
fact, five haplotypes found in the Jackson sample also
were found in the European-derived populations; al-
though it is premature to declare that these haplotypes
are the result of past admixture, the proportion (11%)
is consistent with estimates of European admixture in
the African American population (e.g., see Chakraborty
et al. 1992). At the same time, there will be many varying
sites with frequencies that are similar across populations.
The classic means of measuring population subdivision
is to use F statistics, which partition the total variation
in the population into within- and between-population
components (Wright 1931). F statistics calculated from
blood groups or from allozymes are known to differ
quantitatively from those estimated from nucleotide data
(Cavalli-Sforza et al. 1994): in general, the nucleotide
data are better able to discriminate those differences that
are unique to each population.
When the population structure of haplotypes is con-
sidered, the issue of scale becomes important. Haplo-
types constructed from a region of 1–2 kb are likely to
show some degree of population overlap. However, the
larger the region considered, the smaller the overlap will
be. As the region examined becomes larger, eventually
virtually every individual in the sample will be unique.
With a scale of just 9,734 bp, we found that 81 of the
88 haplotypes are unique to each population sample.
Such population-specific differences seem to provide a
powerful tool for identification, including the tracing of
admixed alleles. Some of this variation will appear as
fixed differences; that is, two groups may be mono-
morphic for different nucleotides. If a phenotype of in-
terest differs markedly between these same two groups,
the cause of the phenotypic differences will be virtually
impossible to ascribe to particular genetic differences,
unless the biochemical mechanism is understood. Of
course, this raises the question of what is the appropriate
scale on which to define functional allelic units. Histor-
ically, the study of genetics has been effective because
single-nucleotide changes that disrupt function of single
genes may have unambiguous phenotypes. For complex
traits, such a simple view cannot be the most effective
way to understand the contribution of genetic variation
to variation in the underlying network of interactions
that are responsible for causation. Our finding that the
haplotypes are organized into two clades that transcend
population subdivision suggests that the unit of function
for the LPL gene is larger than a few single-site
variations.
The third key point is that a thorough population
genetic analysis can be informative with regard to the
forces that have acted to shape the variation that we
observe today. Variation at individual nucleotide sites in
LPL is consistent with a neutral gene in balance between
mutation and random genetic drift, but, when haplo-
types are examined, the data are not compatible with a
simple neutral model. Equilibrium models often are re-
jected when human genetic data are used,mostly because
human populations (including each of our sampled pop-
ulations) have been in a state of expansion and histor-
ically have faced a complex hierarchy of migration and
founding events (Cavalli-Sforza et al. 1994). The obser-
vation of two major clades could not have been caused
by demographic isolation, because the three populations
have roughly the same relative frequencies of the two
major clades. This implies that the two major clades are
very old.
Comparisons with sequences from our nearest rela-
tive, the chimpanzee, serve to illuminate many features
of our own variation. The chimpanzee sequence, as well
as sequences from other hominoid primates, serve to
indicate which of the nucleotides segregating in humans
is ancestral. Such sites may be conserved because, by
chance, no mutations have hit those sites or because the
mutations that did occur were sufficiently deleterious
that they were eliminated from the population. It is re-
markable that one of the nucleotides present in every
segregating site in humans also is present in chimpanzee.
If we root a neighbor-joining tree to the time of common
ancestry of the human and chimpanzee lineages, at 4.6
million years ago, the node joining the LPL lineages
indicates a coalescence time of 1.2 million years ago.
More formal estimates of this date of common ancestry,
based on coalescence theory, are in progress. The intra-
genic recombination requires a more elaborate analysis
than that of Tavare´ et al. (1997). Many studies have
shown an effective population size, revealed by extant
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human genetic variation, to be on the order of 104, and
our estimate of the LPL coalescence time is somewhat
older than the expected 4Ne for a neutral gene. Although
it is tempting to conclude that selection may be main-
taining the two deep clades in the population, many
other nuclear genes exhibit deep ancestry and an excess
of heterozygosity, relative to the infinite-sites model
(Takahata 1995; Takahata et al. 1995; Hey 1997). This
suggests that the departure may have a demographic
cause, and one explanation that is consistent with the
data is an effective population size of 105 for a period
of time after the human/chimpanzee split.
In the LPL subregion sequenced in chimpanzee, 112
sites were found to show fixed differences; that is, chim-
panzee and human have different nucleotides, and there
was no variation at those sites in the sample of humans.
Such fixed divergent sites also may occur because of
either random drift or, possibly, selection. One of the
most powerful tests of evolutionary forces is to compare
levels of intraspecific polymorphism versus levels of in-
terspecific sequence divergence (Hudson et al. 1987). If
mutation and drift are the only forces driving polymor-
phisms and differences between species, then the relative
amount of divergence and polymorphism should be the
same across loci. The DNA-sequence varations in LPL
and b-globin exhibit patterns of within-human poly-
morphism and human/chimpanzee divergence that are
not significantly different from one another, suggesting
a failure to detect heterogeneity in forces that act on the
variability in these two genes.
The fourth feature of the LPL data that merits atten-
tion is the inference that there has been abundant intra-
genic recombination. The rate of recombination (or gene
conversion) may seem surprisingly high: almost as many
recombination events as mutation events have occurred
in the history of the sample of haplotypes that we ex-
amined. This conclusion is based on an assumption that
warrants further examination—namely, that repeated
mutation can be assumed to be absent in these data. If,
despite both the absence of any sites with more than
two nucleotides and the low nucleotide heterozygosity
(.002), there were repeated mutations in these data, then
rates of intragenic recombination would be lower. How-
ever, evidence for intragenic recombination has been de-
tected in many genes inDrosophila (Kreitman and Hud-
son 1991; Schaeffer and Miller 1993; Richter et al.
1997). Furthermore, both local rates of intragenic re-
combination and local levels of DNA-sequence variation
have been shown to vary across the genome, by more
than an order of magnitude, in several organisms, and
these two quantitative measures have been shown to be
correlated positively in both Drosophila (Begun and
Aquadro 1992) and humans (Nachman et al., in press).
The consequences of recombination and gene conversion
on multiple-site disequilibrium can be quite different
(Clark and Zheng 1997), and, despite good estimates of
conversion-tract lengths in Drosophila (Curtis et al.
1989), the relative rates of recombination and conver-
sion are not even known for this model organism.
Despite the evidence for recombination in LPL, it
should be emphasized that there still is considerable link-
age disequilibrium among pairs of sites. The inference
of recombinant haplotypes within LPL is particularly
relevant to the use of anonymous SNPs for detection of
associations with complex diseases. It certainly is not the
case that all such SNPs will give reliable information
about flanking sites. The effectiveness of mapping stud-
ies based on disequilibrium among relatively common
alleles such as these (Collins et al. 1997), as well as the
use of such alleles to find disease association in larger
epidemiological samples, may depend on whether the
causal variants arose early or late relative to the poly-
morphism marked by the typed sites. Several studies al-
ready have shown that there is little association between
linkage disequilibrium and physical distance (Haviland
et al. 1991; Zerba et al. 1991). For example, there are
cases of immediately flanking sites that are in linkage
equilibrium, and examples of population heterogeneity
that produces linkage disequilibrium between genes on
different chromosomes have been cited (Sinnock and
Sing 1972; Zerba et al., in press). The complex historical
processes that gave rise to the contemporary patterns of
linkage disequilibrium suggest that the simple relation
may have little value in the prediction of′ tD  (1 r)D
the fate of linkage disequilibrium in human populations.
The issues raised by the complete sequences fromLPL
have led us to revisit a number of articles published in
the 1980s, when RFLPs were first used to identify hap-
lotypes based on multiple markers in short human chro-
mosome regions. An example of this work is a study of
a 61-kb region of chromosome 11, including the apoAI/
CIII/AIV apolipoprotein gene complex, screened by re-
striction enzymes (Antonarakis et al. 1988). Eleven
RFLP sites were used to identify haplotypes, from nu-
clear families, for 129 Mediterranean and 67 African
American chromosomes. Whereas only a minority of
these sites were in pairwise disequilibrium, most of these
were in maximum disequilibrium.When completeDNA-
sequence data are considered, this picture seems to
change considerably. Compared with the apoAI/CIII/
AIV gene region, the LPL-sequence data appear to ex-
hibit more recombination and less linkage disequilib-
rium. However, the high prevalence of four-gamete re-
lationships in the RFLP-study data, as in our LPL
sample, suggests that recombination was common
among restriction sites as well. Because so many addi-
tional varying sites were included, the LPL data provide
sufficient detail to make nearly all haplotypes unique. If
we were to consider only small numbers of LPL sites,
we also would identify fewer haplotypes, as well as a
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more tractable frequency distribution, evidence for dis-
equilibrium, and broader sharing of the same haplotype
among populations.
A number of other studies of RFLP haplotypes at can-
didate susceptibility loci were performed in the 1980s
(e.g., Chakravarti et al. 1984, 1986; Leitersdorf et al.
1989). The details vary among studies, but the basic
findings are qualitatively similar. Many more haplotypes
were found than were expected, but not nearly as many
per kilobase as were found in the LPL data. Multiple
occurrences of four-gamete states were present among
the restriction sites, in samples of roughly the same scale
and population diversity as those for the LPL data, with
only partial and patchy disequilibrium among the RFLP
sites. These RFLP studies revealed evidence for recom-
bination hot spots between major regions of the genes
under consideration, just as the Jakobsen et al. (1997)
test did for the LPL data. In the RFLP era, disequilib-
rium was considered to be undesirable, because the ob-
jective was to identify multiple variant sites as indepen-
dent potential markers for intervening causal variants.
For population association studies based on linkage dis-
equilibrium, investigators recently have suggested de-
veloping dense SNPmaps (Collins et al. 1997). However,
our LPL data show that, at the sequence level, this may
not be so simple. Although it is true that many site pairs
are found in linkage disequilibrium, the structure of dis-
equilibrium would lead to unacceptably high type II er-
ror rates; that is, a closely linked functional locus would
not be detected, because of linkage equilibrium between
the SNP and the functional locus.
A more recent study used DNA sequencing to identify
all variation in a 3-kb region of the human b-globin gene
in 349 chromosomes obtained from individuals from
many different populations (Harding et al. 1997). Dif-
ferent regions of the gene had different densities of hap-
lotypes (as also was seen by our sliding window of 5 or
10 sites in LPL), suggesting different levels of past re-
combination effects, including a known recombination
hot spot. In 349 sequences in a 2.67-kb subregion, 23
haplotypes clearly were recombinants. When these re-
combinants were excluded from further analysis, the re-
maining haplotypes fitted a cladistic structure that did
not suggest the kind of global two-clade structure that
we found in LPL.Overall, the globin-sequence variation
revealed an average nucleotide diversity of .0018, in-
dicating levels of variation very similar to those in LPL.
Many of our findings may seem to be inconsistentwith
the success of a number of investigators in the identifi-
cation of genes for disease phenotypes in populations
founded relatively recently by a small number of indi-
viduals. Examples are the Amish population, in which
Hirschprung disease has been studied (Chakravarti
1996), and studies of North Karelia populations, in
which a number of diseases have been mapped success-
fully (Peltonen 1996). Such successes have led to the view
that a dense SNP map—being even more definitive,
in terms of a simpler underlying mutational pro-
cess—would be useful in an even broader population
context (e.g., the United States). The explanation for this
apparent inconsistency seems to be straightforward.
First, the disease phenotypes mapped in this way, to date,
usually are rare, often are of single-locus etiology, and
exhibit clear Mendelian inheritance in families. In a
small population, such traits are likely to have only a
small number of causal alleles, so that samples ascer-
tained by such “phenotypes” are likely to comprise
clones of descendants of the founding allele(s).
In principle, we should face an easier situation with
a known candidate gene, such as LPL, for which the
key role in lipid physiology has been clearly established.
However, we have documented sufficient variation in a
complex pattern of linkage disequilibrium that associ-
ation studies would require inordinate sample sizes in
order to ascribe cause to particular nucleotide sites. At
present, it is not practical to consider the sequencing of
complete candidate genes in thousands of individuals;
therefore, some form of data reduction is necessary. Our
objective is to use the sample reported here to identify
a subset of variations that can be typed in thousands of
individuals measured for CHD risk factors in these pop-
ulations, in order to detect risk-factor phenotypes as-
sociated with the chosen subset of sites used as markers.
The data presented in this article suggest that a blind
association or disequilibrium test, with three or four ran-
dom markers chosen from variable sites even within 10
kb of the LPL gene, would not be a reliable method of
detection of nearby causal variation. An obvious alter-
native is to find a subset of sites that capture the cladistic,
or disequilibrium, structure of variation in the whole
gene (Templeton 1996). Our inference of intragenic re-
combination in LPL is based on the assumption that
recombination, rather than repeated mutation, at a site
caused site pairs to have all four gametes present. If,
instead, we assume that repeated mutation occurs fre-
quently and only accept recombination when such site
pairs are clustered significantly (Crandall and Templeton
1998), then the apparent number of recombination
events will be decreased. Application of cladistic meth-
ods may be possible in this case, but it will require novel
approaches. For the same reason, large association or
disequilibrium-mapping studies probably should be un-
dertaken only after a clear picture of the underlying
structure of DNA-sequence variation in the targeted
populations has been obtained. Investigators contem-
plating such studies should be aware that the develop-
ment of reliable association tests may be limited by the
complexities of intragenic recombination, population
substructure, and an intricate, hierarchical pattern of
linkage disequilibrium.
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